JP2013519379A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013519379A5 JP2013519379A5 JP2012553038A JP2012553038A JP2013519379A5 JP 2013519379 A5 JP2013519379 A5 JP 2013519379A5 JP 2012553038 A JP2012553038 A JP 2012553038A JP 2012553038 A JP2012553038 A JP 2012553038A JP 2013519379 A5 JP2013519379 A5 JP 2013519379A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- cell
- seq
- immunoglobulin
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30425110P | 2010-02-12 | 2010-02-12 | |
| US61/304,251 | 2010-02-12 | ||
| US201161437889P | 2011-01-31 | 2011-01-31 | |
| US61/437,889 | 2011-01-31 | ||
| PCT/US2011/024554 WO2011100566A2 (en) | 2010-02-12 | 2011-02-11 | Methods for identifying and isolating cells expressing a polypeptide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016139165A Division JP2017014220A (ja) | 2010-02-12 | 2016-07-14 | ポリペプチド発現細胞の同定及び単離の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013519379A JP2013519379A (ja) | 2013-05-30 |
| JP2013519379A5 true JP2013519379A5 (cg-RX-API-DMAC7.html) | 2014-04-03 |
| JP6034696B2 JP6034696B2 (ja) | 2016-11-30 |
Family
ID=44368462
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012553038A Expired - Fee Related JP6034696B2 (ja) | 2010-02-12 | 2011-02-11 | ポリペプチド発現細胞の同定及び単離の方法 |
| JP2016139165A Withdrawn JP2017014220A (ja) | 2010-02-12 | 2016-07-14 | ポリペプチド発現細胞の同定及び単離の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016139165A Withdrawn JP2017014220A (ja) | 2010-02-12 | 2016-07-14 | ポリペプチド発現細胞の同定及び単離の方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US8551715B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2534257B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6034696B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20120117931A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102844442B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011215685B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2789446A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL221349A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2012009175A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ601743A (cg-RX-API-DMAC7.html) |
| SG (2) | SG10201503736XA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011100566A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7919092B2 (en) | 2006-06-13 | 2011-04-05 | Oncomed Pharmaceuticals, Inc. | Antibodies to notch receptors |
| HRP20160082T1 (hr) | 2006-09-29 | 2016-02-26 | Oncomed Pharmaceuticals, Inc. | Sastavi i postupci za dijagnosticiranje i lijeäśenje raka |
| WO2008091641A2 (en) | 2007-01-24 | 2008-07-31 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
| US9249423B2 (en) | 2007-02-02 | 2016-02-02 | Yale University | Method of de-differentiating and re-differentiating somatic cells using RNA |
| WO2008097926A2 (en) * | 2007-02-02 | 2008-08-14 | Yale University | Transient transfection with rna |
| US10155038B2 (en) | 2007-02-02 | 2018-12-18 | Yale University | Cells prepared by transient transfection and methods of use thereof |
| CN102112490B (zh) | 2008-07-08 | 2014-10-22 | 昂考梅德药品有限公司 | Notch1受体结合剂和其使用方法 |
| US9132189B2 (en) | 2008-07-08 | 2015-09-15 | Oncomed Pharmaceuticals, Inc. | Notch1 binding agents and methods of use thereof |
| EP3485908B1 (en) | 2009-10-16 | 2021-08-18 | Mereo BioPharma 5, Inc. | Therapeutic combination and use of dll4 antagonist antibodies and anti-hypertensive agents |
| KR20120117931A (ko) | 2010-02-12 | 2012-10-24 | 온코메드 파마슈티칼스, 인크. | 폴리펩타이드를 발현하는 세포를 확인 및 분리하는 방법 |
| US8551479B2 (en) | 2010-09-10 | 2013-10-08 | Oncomed Pharmaceuticals, Inc. | Methods for treating melanoma |
| US9365846B2 (en) | 2010-12-01 | 2016-06-14 | Merck Sharp & Dohme Corp. | Surface, anchored Fc-bait antibody display system |
| US10106598B2 (en) | 2010-12-01 | 2018-10-23 | Merck Sharp & Dohme Corp. | Surface, anchored Fc-bait antibody display system |
| WO2013012747A1 (en) | 2011-07-15 | 2013-01-24 | Oncomed Pharmaceuticals, Inc. | Rspo binding agents and uses thereof |
| TWI583699B (zh) | 2011-09-23 | 2017-05-21 | 安可美德藥物股份有限公司 | Vegf/dll4結合劑類及彼等之用途 |
| MX2014014951A (es) | 2012-06-06 | 2015-03-13 | Oncomed Pharm Inc | Agentes aglutinantes que modulan la trayectoria hippo y sus usos. |
| CN104854132A (zh) | 2012-07-13 | 2015-08-19 | 昂考梅德药品有限公司 | Rspo3结合剂及其用途 |
| PL3489261T3 (pl) | 2012-08-24 | 2021-08-16 | The Regents Of The University Of California | Przeciwciała i szczepionki do stosowania w leczeniu nowotworów z ekspresją ROR1 i w hamowaniu przerzutu |
| WO2014062659A2 (en) * | 2012-10-15 | 2014-04-24 | Oncomed Pharmaceuticals, Inc. | Methods of treating ocular diseases |
| US8921055B2 (en) * | 2012-10-30 | 2014-12-30 | Berkeley Lights, Inc. | Detecting cells secreting a protein of interest |
| CA2889638A1 (en) | 2012-10-31 | 2014-05-08 | Oncomed Pharmaceuticals, Inc. | Methods and monitoring of treatment with a dll4 antagonist |
| EP2934532B1 (en) | 2012-12-20 | 2019-10-23 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| AU2014249148B2 (en) * | 2013-03-11 | 2020-04-02 | Regeneron Pharmaceuticals, Inc. | Transgenic mice expressing chimeric major histocompatibility complex (mhc) class ii molecules |
| GB201405845D0 (en) | 2014-04-01 | 2014-05-14 | Ucl Business Plc | Signalling system |
| GB201407852D0 (en) | 2014-05-02 | 2014-06-18 | Iontas Ltd | Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules |
| GB201415347D0 (en) * | 2014-08-29 | 2014-10-15 | Ucl Business Plc | Signalling system |
| EP3212233B1 (en) | 2014-10-31 | 2020-06-24 | Oncomed Pharmaceuticals, Inc. | Combination therapy for treatment of disease |
| CA2966988A1 (en) * | 2014-11-06 | 2016-05-12 | Children's Research Institute, Children's National Medical Center | Immunotherapeutics for cancer and autoimmune diseases |
| CN107429253B (zh) | 2014-12-05 | 2021-11-05 | 希望之城公司 | Cs1靶向性嵌合抗原受体修饰的t细胞 |
| TWI715587B (zh) | 2015-05-28 | 2021-01-11 | 美商安可美德藥物股份有限公司 | Tigit結合劑和彼之用途 |
| US11339213B2 (en) | 2015-09-23 | 2022-05-24 | Mereo Biopharma 5, Inc. | Methods and compositions for treatment of cancer |
| CA3019835A1 (en) | 2016-04-08 | 2017-10-12 | Purdue Research Foundation | Methods and compositions for car t cell therapy |
| KR20230047507A (ko) | 2016-06-27 | 2023-04-07 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 암 치료 조합 |
| MX2019006072A (es) | 2016-11-30 | 2019-08-14 | Oncomed Pharm Inc | Metodos para tratamiento de cancer que comprenden agentes de enlace al inmunoreceptor de celulas t con dominios ige itim (tigit). |
| AU2018219226B2 (en) | 2017-02-07 | 2024-12-19 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents |
| CN110582288B (zh) | 2017-02-28 | 2024-09-20 | 恩多塞特公司 | 用于car t细胞疗法的组合物和方法 |
| JP7287940B2 (ja) | 2017-03-24 | 2023-06-06 | ランケナウ・インスティテュート・フォー・メディカル・リサーチ | ハイブリドーマによって分泌されるモノクローナル免疫グロブリンの誘導性細胞外膜捕捉のための方法及び組成物 |
| WO2019144095A1 (en) | 2018-01-22 | 2019-07-25 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Methods of use for car t cells |
| AU2019218729B2 (en) | 2018-02-06 | 2025-12-04 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Fluorescein-specific CARs exhibiting optimal T cell function against FL-PLE labelled tumors |
| JP7568224B2 (ja) | 2018-02-23 | 2024-10-16 | エンドサイト・インコーポレイテッド | Car t細胞療法のための配列決定法 |
| CN112930186A (zh) | 2018-08-16 | 2021-06-08 | 纪念斯隆-凯特琳癌症中心 | 基于亮氨酸拉链的组合物和使用方法 |
| CN112996819B (zh) * | 2018-08-16 | 2025-11-04 | 纪念斯隆-凯特琳癌症中心 | 细胞分选系统及使用方法 |
| CN112969476B (zh) * | 2018-12-07 | 2024-06-14 | 江苏恒瑞医药股份有限公司 | 多特异性蛋白分子 |
| CN109738506B (zh) * | 2019-01-10 | 2021-02-26 | 青岛大学附属医院 | 一种成熟脂肪细胞中自噬相关蛋白乙酰化位点研究方法 |
| WO2020210816A1 (en) * | 2019-04-12 | 2020-10-15 | Methodist Hospital Research Institute | Therapeutic particles that enable antigen presenting cells to attack cancer cells |
| IL295063A (en) | 2020-02-04 | 2022-09-01 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Chimeric antigen receptors (car) against dinitrophenol |
| JP2024531431A (ja) | 2021-08-25 | 2024-08-29 | イオンタス リミテッド | 真核細胞で発現するタンパク質変異体のライブラリーの調製 |
| EP4526351A2 (en) * | 2022-05-16 | 2025-03-26 | City of Hope | Anti-cd84 antibodies and uses thereof |
| KR20250141200A (ko) * | 2023-02-01 | 2025-09-26 | 알렌 인스티튜트 | 전압-게이팅 나트륨 채널 기능의 인테인 매개 재구성 |
| WO2024251820A1 (en) | 2023-06-06 | 2024-12-12 | Iontas Limited | Preparation of libraries of bispecific binders expressed in eukaryotic cells |
| CN122497524A (zh) * | 2024-01-12 | 2026-07-31 | 索诺玛生物治疗公司 | 具有非典型跨膜结构域和/或铰链结构域的嵌合抗原受体 |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
| US7166423B1 (en) | 1992-10-21 | 2007-01-23 | Miltenyi Biotec Gmbh | Direct selection of cells by secretion product |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US6121022A (en) | 1995-04-14 | 2000-09-19 | Genentech, Inc. | Altered polypeptides with increased half-life |
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| EP0859841B1 (en) | 1995-08-18 | 2002-06-19 | MorphoSys AG | Protein/(poly)peptide libraries |
| US6828422B1 (en) | 1995-08-18 | 2004-12-07 | Morphosys Ag | Protein/(poly)peptide libraries |
| EP0937095A4 (en) * | 1996-10-25 | 1999-12-22 | Cell Genesys Inc | TARGETED CYTOLYSIS OF CANCER CELLS |
| WO1998041613A1 (en) * | 1997-03-14 | 1998-09-24 | Otten Gillis R | Targeted cytolysis of cancer cells |
| ES2513043T3 (es) * | 1997-03-26 | 2014-10-24 | Imperial Innovations Limited | Proteína de fusión anticoagulante anclada a membrana de la célula |
| US5837994C1 (en) | 1997-04-02 | 2001-10-16 | Gentex Corp | Control system to automatically dim vehicle head lamps |
| US7176179B1 (en) * | 1997-05-30 | 2007-02-13 | The Regents Of The University Of California | Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide |
| JP3614866B2 (ja) | 1997-06-12 | 2005-01-26 | リサーチ コーポレイション テクノロジーズ,インコーポレイティド | 人工抗体ポリペプチド |
| US6180343B1 (en) | 1998-10-08 | 2001-01-30 | Rigel Pharmaceuticals, Inc. | Green fluorescent protein fusions with random peptides |
| US6197294B1 (en) * | 1998-10-26 | 2001-03-06 | Neurotech S.A. | Cell surface molecule-induced macrophage activation |
| DE19900635A1 (de) * | 1999-01-11 | 2000-07-13 | Deutsches Krebsforsch | Selektion von monoklonalen Antikörpern |
| ATE482275T1 (de) | 1999-07-02 | 2010-10-15 | Morphosys Ag | Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden |
| US7498304B2 (en) * | 2000-06-16 | 2009-03-03 | Curis, Inc. | Angiogenesis-modulating compositions and uses |
| US7094571B2 (en) | 2000-10-27 | 2006-08-22 | The Board Of Regents Of The University Of Texas System | Combinatorial protein library screening by periplasmic expression |
| CN1306272C (zh) * | 2000-11-17 | 2007-03-21 | 罗切斯特大学 | 筛选编码抗原特异性免疫球蛋白分子或其抗原特异性片段的方法 |
| ATE325865T1 (de) | 2001-01-16 | 2006-06-15 | Regeneron Pharma | Isolierung von sezernierte proteine exprimierenden zellen |
| US20030171546A1 (en) * | 2001-04-30 | 2003-09-11 | City Of Hope | Chimeric immunoreceptor useful in treating human cancers |
| WO2003106639A2 (en) | 2002-06-14 | 2003-12-24 | Dyax Corporation | Recombination of nucleic acid library members |
| JP4748984B2 (ja) * | 2002-06-16 | 2011-08-17 | ダイアックス、コープ | 核酸ライブラリーメンバーの組換え |
| EP1636561B1 (en) * | 2002-07-15 | 2011-02-09 | Board Of Regents, The University Of Texas System | Combinatorial protein library screening by periplasmic expression |
| FR2849039B1 (fr) | 2002-12-24 | 2010-10-01 | Centre Nat Rech Scient | Nouvelle proteine associee aux centrosomes et ses applications |
| EP1447413A3 (en) * | 2003-02-14 | 2006-01-04 | Research Association for Biotechnology | Full-length human cDNA |
| US20070048740A1 (en) | 2003-02-14 | 2007-03-01 | Research Association For Biotechnology | Full-length cDNA |
| US7479538B2 (en) * | 2004-11-12 | 2009-01-20 | The Zhabilov Trust | Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising the same for detecting, preventing, and treating HIV |
| AU2006304387A1 (en) * | 2005-10-14 | 2007-04-26 | Medimmune, Llc | Cell display of antibody libraries |
| WO2007115230A2 (en) * | 2006-03-30 | 2007-10-11 | University Of Medicine And Dentistry Of New Jersey | A strategy for homo- or hetero-dimerization of various proteins in solutions and in cells |
| EP2068914A4 (en) * | 2007-02-09 | 2011-07-20 | Medimmune Llc | PRESENTATION OF ANTIBODY BANK BY PLASMA MEMBRANES OF YEAST CELLS |
| US8067339B2 (en) | 2008-07-09 | 2011-11-29 | Merck Sharp & Dohme Corp. | Surface display of whole antibodies in eukaryotes |
| KR20120117931A (ko) | 2010-02-12 | 2012-10-24 | 온코메드 파마슈티칼스, 인크. | 폴리펩타이드를 발현하는 세포를 확인 및 분리하는 방법 |
| US9365846B2 (en) * | 2010-12-01 | 2016-06-14 | Merck Sharp & Dohme Corp. | Surface, anchored Fc-bait antibody display system |
-
2011
- 2011-02-11 KR KR1020127023732A patent/KR20120117931A/ko not_active Ceased
- 2011-02-11 JP JP2012553038A patent/JP6034696B2/ja not_active Expired - Fee Related
- 2011-02-11 WO PCT/US2011/024554 patent/WO2011100566A2/en not_active Ceased
- 2011-02-11 NZ NZ601743A patent/NZ601743A/en not_active IP Right Cessation
- 2011-02-11 AU AU2011215685A patent/AU2011215685B2/en not_active Ceased
- 2011-02-11 MX MX2012009175A patent/MX2012009175A/es active IP Right Grant
- 2011-02-11 CN CN201180009377.8A patent/CN102844442B/zh not_active Expired - Fee Related
- 2011-02-11 SG SG10201503736XA patent/SG10201503736XA/en unknown
- 2011-02-11 EP EP11742877.1A patent/EP2534257B1/en active Active
- 2011-02-11 US US13/025,733 patent/US8551715B2/en not_active Expired - Fee Related
- 2011-02-11 SG SG2012058194A patent/SG183196A1/en unknown
- 2011-02-11 CA CA2789446A patent/CA2789446A1/en not_active Abandoned
-
2012
- 2012-08-08 IL IL221349A patent/IL221349A0/en unknown
-
2013
- 2013-09-06 US US14/020,012 patent/US9023621B2/en not_active Expired - Fee Related
- 2013-09-06 US US14/020,030 patent/US8945878B2/en not_active Expired - Fee Related
-
2015
- 2015-04-03 US US14/678,592 patent/US9422546B2/en not_active Expired - Fee Related
-
2016
- 2016-07-14 US US15/210,250 patent/US9873726B2/en not_active Expired - Fee Related
- 2016-07-14 JP JP2016139165A patent/JP2017014220A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7150880B2 (ja) | 抗-b7-h3抗体およびその用途 | |
| JP7287963B2 (ja) | 抗tigit抗体並びに治療剤及び診断剤としてのその使用 | |
| KR101455447B1 (ko) | Muc1* 항체 | |
| CN107880128B (zh) | 一种抗cd19的全人源抗体或抗体片段及其方法和应用 | |
| CN112574307A (zh) | 抗人Claudin18.2抗体及其应用 | |
| EP3999550A1 (en) | Anti-dll3 chimeric antigen receptors and uses thereof | |
| TW202332697A (zh) | 細胞傷害誘導治療劑 | |
| KR20190044626A (ko) | 항-cd19 항체에 대한 항-이디오타입 항체 | |
| CN109661235B (zh) | 抗原结合分子及其使用的方法 | |
| CA2947157A1 (en) | T cell-redirected antigen-binding molecule for cells having immunosuppression function | |
| CA3117756A1 (en) | Novel agonistic antibody molecules | |
| JPWO2017086419A1 (ja) | 液性免疫応答の増強方法 | |
| JP2017536412A (ja) | T細胞再標的化ヘテロ二量体免疫グロブリン | |
| CN104829727B (zh) | 一种双特异性抗体cd19×cd3的构建及应用 | |
| JP2024153077A (ja) | 微小ガイダンス及びナビゲーションコントロール(miniGNC)抗体様タンパク質、その製造方法及び使用方法 | |
| TW202221042A (zh) | Pd-1/vegf四價雙特異性抗體、其製備方法和用途 | |
| JP2025503573A (ja) | 抗gprc5d抗体及びその応用 | |
| CA3117864A1 (en) | Novel antagonistic anti tnfr2 antibody molecules | |
| JP2024512957A (ja) | Cd3に結合する多重特異性抗原結合タンパク質とその使用方法 | |
| CN113912731A (zh) | 一种抗fgl1抗体及其应用 | |
| US20250000976A1 (en) | Anti-bcma single domain antibodies and therapeutic constructs | |
| JP2025504795A (ja) | 抗体及びその用途 | |
| JP2025505650A (ja) | 抗イディオタイプ抗体分子及びその使用 | |
| CN112794907A (zh) | 一株全人源抗人huOX40单克隆抗体 | |
| CN113423720A (zh) | CAR文库和scFv的制造方法 |